The excessive tissue damage induced by conditioning therapy leads to NLRP3 inflammasome activation that promotes IL-1β and IL-18 production, which prime immune cells implicated in the inflammatory response typical of GvHD [39]. The gene discussed is IL1B; the disease is graft versus host disease.